Highlights and Quick Summary
Current Net Cash/Marketcap of Biofrontera AG Sponsored ADR is $-0.0487 (as of December 31, 2021)
- Net Cash/Marketcap for the quarter ending June 30, 2022 was $0.0004 (a -100.61% decrease compared to previous quarter)
- Year-over-year quarterly Net Cash/Marketcap decreased by -100.82%
- Annual Net Cash/Marketcap for 2021 was $-0.0487 (a -205.64% decrease from previous year)
- Annual Net Cash/Marketcap for 2021 was $0.0461 (a -8.89% decrease from previous year)
- Annual Net Cash/Marketcap for 2020 was $0.0506 (a -16.09% decrease from previous year)
Visit stockrow.com/BFAGY
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Net Cash/Marketcap of Biofrontera AG Sponsored ADR
Most recent Net Cash/Marketcapof BFAGY including historical data for past 10 years.Interactive Chart of Net Cash/Marketcap of Biofrontera AG Sponsored ADR
Biofrontera AG Sponsored ADR Net Cash/Marketcap for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | – | $0.0 | $0.0 | – |
| 2021 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2020 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2019 | – | $0.0 | $0.0 | $0.0 | $0.0 |
| 2018 | – | – | – | $0.0 | $0.0 |
| 2017 | – | – | $0.0 | $0.0 | $0.0 |
| 2016 | $0.0 | – | – | – | $0.0 |
Business Profile of Biofrontera AG Sponsored ADR
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic